Healthcare Virtual Assistants Market Size Worth $5.31Bn, Globally, by 2028 at 34.01% CAGR - Exclusive Report by The Insight Partners
February 17, 2022 08:22 ET
|
The Insight Partners
New York, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Healthcare Virtual Assistants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Fall Management Market Size Worth $230.10 Mn, Globally, by 2028 at 4.3% CAGR - Exclusive Report by The Insight Partners
February 17, 2022 05:29 ET
|
The Insight Partners
New York, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Fall Management Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Sensor...
BioNTech stellt erste modulare mRNA-Produktionsanlage zur Unterstützung einer skalierbaren Impfstoffproduktion in Afrika vor
February 16, 2022 05:30 ET
|
BioNTech SE
Entwicklung von schlüsselfertigen modularen Produktionsanlagen als Lösung für eine skalierbare Herstellung von mRNA-basierten Impfstoffen; Anlagen werden von BioNTech eingerichtetTreffen der...
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
February 16, 2022 05:30 ET
|
BioNTech SE
Developing turnkey solution to enable mRNA-based vaccine production in modular and scalable sites installed by BioNTech Presidents of Ghana, Rwanda, Senegal, the Director-General of the World Health...
BioNTech nimmt an Spitzentreffen mit Partnern in Marburg teil und hält Pressekonferenz zu Plänen für nachhaltige Impfstoffherstellung in Afrika
February 15, 2022 09:40 ET
|
BioNTech SE
MAINZ, Deutschland, 15. Februar 2022 – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird Projektpartner, darunter auch offizielle Regierungsvertreter und –vertreterinnen, bei einem...
BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference to Provide an Update on Sustainable Vaccine Manufacturing in Africa
February 15, 2022 09:40 ET
|
BioNTech SE
MAINZ, Germany, February 15, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will welcome project partners, among them official representatives, in Marburg to conduct a high-level...
$3.06Bn by 2027, Pharmaceutical Continuous Manufacturing Market Size, 9.8% CAGR Lead by Integrated Systems - Exclusive Research Report by The Insight Partners
February 09, 2022 08:47 ET
|
The Insight Partners
New York, Feb. 09, 2022 (GLOBE NEWSWIRE) -- According to our new research study on “Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product...
DEPRESSION PATENT FOR OROTATE APPROVED & GRANTED BY US PATENT OFFICE
October 11, 2021 10:40 ET
|
Medlab Clinical Ltd
SYDNEY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Medlab Clinical LTD (ASX:MDC) is pleased to announce the Orotate patent, specifically to addressing depression in United States of America has been granted....
Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion’s DNA-based Vaccine
September 17, 2021 09:00 ET
|
Celsion CORP
Expands GEN-1 Program Collaboration to Add Clinical and Commercial Batches of Investigational Vaccine LAWRENCEVILLE, N.J. and HAINAN, China, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation...
Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent
July 27, 2021 08:20 ET
|
Dyadic International, Inc.
Arrangement includes C1 COVID-19 vaccine technology transfer and licensing agreementProvides potential funding pathway for a C1 manufactured COVID-19 vaccine to progress through Phase II and Phase III...